Product Information

MORPHINE SULFATE IR 30 MG TAB is a generic product labeled by SpecGx LLC, priced at $0.3657 per EA under NDC 00406511962. Its NADAC has been published 154 times since Dec 13, 2023.

FDA first approved this application on Aug 21, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MORPHINE SULFATE IR 30 MG TAB

Morphine Sulfate
$0.3657per EA
DEA Schedule CII

Strength

30 mg/1

Manufacturer

SpecGx LLC

NDC

00406511962

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

MORPHINE SULFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA215194

FDA Approved

8/21/2023

TE Code

AB

On Market Since

9/1/2023

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price Statistics

The NADAC for MORPHINE SULFATE IR 30 MG TAB has been published 154 times since Dec 13, 2023, and over the history we have for it it has declined 4.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3657 per EA
All-time high$0.4546 (Dec 10, 2025)
All-time low$0.2773 (Nov 20, 2024)
52-week high$0.4546
52-week low$0.3414
Median price$0.3991
Average price$0.3873
Largest weekly change-34.0% (Nov 20, 2024)
Weeks tracked154
Tracking sinceDec 13, 2023

Price History

1W

+3.2%

1M

+7.1%

3M

+2.1%

6M

-8.8%

1Y

-17.9%

3Y

N/A

5Y

N/A

All

-4.1%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MORPHINE SULFATE IR 30 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for MORPHINE SULFATE IR 30 MG TAB, manufactured by SpecGx LLC, is $0.3657 per EA (NDC 00406511962), effective Nov 18, 2026.

How has the price of MORPHINE SULFATE IR 30 MG TAB changed over time?

Over the history we have for it, the NADAC for MORPHINE SULFATE IR 30 MG TAB has declined 4.1%. It has been tracked across 154 weekly CMS publications since Dec 13, 2023.

What are the highest and lowest recorded NADAC prices for MORPHINE SULFATE IR 30 MG TAB?

Since Dec 13, 2023, the NADAC for MORPHINE SULFATE IR 30 MG TAB has ranged from a low of $0.2773 (Nov 20, 2024) to a high of $0.4546 (Dec 10, 2025), with a median of $0.3991 per EA.

Are there cheaper alternatives to MORPHINE SULFATE IR 30 MG TAB?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MORPHINE SULF ER 30 MG TABLET, is $0.3462 per EA — about 5% below MORPHINE SULFATE IR 30 MG TAB.

Who manufactures MORPHINE SULFATE IR 30 MG TAB?

MORPHINE SULFATE IR 30 MG TAB (NDC 00406511962) is labeled by SpecGx LLC, and CMS classifies it as a generic product.